This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Plettenberg, A. Articles by Tschachler, E. Search for Related Content PubMed PubMed Citation Articles by Plettenberg, A. Articles by Tschachler, E.

American Journal of Pathology, Vol 146, 651-659, Copyright © 1995 by American Society for Investigative Pathology

REGULAR ARTICLES

Human melanocytes and melanoma cells constitutively express the Bcl-2 proto-oncogene in situ and in cell culture

A Plettenberg, C Ballaun, J Pammer, M Mildner, D Strunk, W Weninger and E Tschachler
Department of Dermatology, University of Vienna Medical School, Austria.

The Bcl-2 proto-oncogene regulates cell survival by antagonizing events that lead to apoptotic cell death and has been reported to be expressed in situ in lymphoid tissues, glandular epithelium, neurons, and basal epidermal cells. When we performed immunostaining on cryostat sections of normal skin, anti-Bcl-2 reactivity was confined to scattered dendritic cells in the basal epidermal layer. Double-staining experiments showed that the Bcl-2+ cells were positive for vimentin but negative for cytokeratins, CD1a, and CD45 antigens, excluding keratinocytes and Langerhans cells as possible candidates for constitutive Bcl-2 expression. Bcl-2+ epidermal cells also reacted with the monoclonal anti-melanocyte antibody NKI/beteb, and were absent from lesional skin in vitiligo, confirming that they represented epidermal melanocytes. Western blot analysis of cultured melanocytes and melanoma cell lines revealed a 26-kd protein specifically reacting with the anti- Bcl-2 monoclonal antibody. Immunostaining of pigmented lesions revealed strong expression of Bcl-2 by five of five nevocellular nevi and seven of seven melanomas. Our observations demonstrate that, within normal human epidermis, melanocytes are the only cells that express Bcl-2 constitutively and that Bcl-2 is expressed in benign and malignant pigmented tumors of the skin in situ.

This article has been cited by other articles:

				L. Chin, L. A. Garraway, and D. E. Fisher Malignant melanoma: genetics and therapeutics in the genomic era. Genes & Dev., August 15, 2006; 20(16): 2149 - 2182. [Abstract] [Full Text] [PDF]

				L. Benimetskaya, K. Ayyanar, N. Kornblum, D. Castanotto, J. Rossi, S. Wu, J. Lai, B. D. Brown, N. Popova, P. Miller, et al. Bcl-2 Protein in 518A2 Melanoma Cells In vivo and In vitro. Clin. Cancer Res., August 15, 2006; 12(16): 4940 - 4948. [Abstract] [Full Text] [PDF]

				A. L. Kadekaro, R. Kavanagh, H. Kanto, S. Terzieva, J. Hauser, N. Kobayashi, S. Schwemberger, J. Cornelius, G. Babcock, H. G. Shertzer, et al. {alpha}-Melanocortin and Endothelin-1 Activate Antiapoptotic Pathways and Reduce DNA Damage in Human Melanocytes Cancer Res., May 15, 2005; 65(10): 4292 - 4299. [Abstract] [Full Text] [PDF]

				M. Bohm, I. Wolff, T. E. Scholzen, S. J. Robinson, E. Healy, T. A. Luger, T. Schwarz, and A. Schwarz {alpha}-Melanocyte-stimulating Hormone Protects from Ultraviolet Radiation-induced Apoptosis and DNA Damage J. Biol. Chem., February 18, 2005; 280(7): 5795 - 5802. [Abstract] [Full Text] [PDF]

				L. Benimetskaya, J. C. Lai, A. Khvorova, S. Wu, E. Hua, P. Miller, L.-M. Zhang, and C. A. Stein Relative Bcl-2 Independence of Drug-Induced Cytotoxicity and Resistance in 518A2 Melanoma Cells Clin. Cancer Res., December 15, 2004; 10(24): 8371 - 8379. [Abstract] [Full Text] [PDF]

				K. A. DiVito, A. J. Berger, R. L. Camp, M. Dolled-Filhart, D. L. Rimm, and H. M. Kluger Automated Quantitative Analysis of Tissue Microarrays Reveals an Association between High Bcl-2 Expression and Improved Outcome in Melanoma Cancer Res., December 1, 2004; 64(23): 8773 - 8777. [Abstract] [Full Text] [PDF]

				C. Perlis and M. Herlyn Recent Advances in Melanoma Biology Oncologist, April 1, 2004; 9(2): 182 - 187. [Abstract] [Full Text] [PDF]

				Q. Wei, J. E. Lee, J. E. Gershenwald, M. I. Ross, P. F. Mansfield, S. S. Strom, L.-E Wang, Z. Guo, Y. Qiao, C. I. Amos, et al. Repair of UV Light-Induced DNA Damage and Risk of Cutaneous Malignant Melanoma J Natl Cancer Inst, February 19, 2003; 95(4): 308 - 315. [Abstract] [Full Text] [PDF]

				M. Mildner, L. Eckhart, B. Lengauer, and E. Tschachler Hepatocyte Growth Factor/Scatter Factor Inhibits UVB-induced Apoptosis of Human Keratinocytes but Not of Keratinocyte-derived Cell Lines via the Phosphatidylinositol 3-Kinase/AKT Pathway J. Biol. Chem., April 12, 2002; 277(16): 14146 - 14152. [Abstract] [Full Text] [PDF]

				H. Rossiter, S. Beissert, C. Mayer, M. P. Schön, B. G. Wienrich, E. Tschachler, and T. S. Kupper Targeted Expression of bcl-2 to Murine Basal Epidermal Keratinocytes Results in Paradoxical Retardation of Ultraviolet- and Chemical-induced Tumorigenesis Cancer Res., May 1, 2001; 61(9): 3619 - 3626. [Abstract] [Full Text]

				E. Petitclerc, S. Stromblad, T. L. von Schalscha, F. Mitjans, J. Piulats, A. M. P. Montgomery, D. A. Cheresh, and P. C. Brooks Integrin {{alpha}}V{beta}3 Promotes M21 Melanoma Growth in Human Skin by Regulating Tumor Cell Survival Cancer Res., June 1, 1999; 59(11): 2724 - 2730. [Abstract] [Full Text] [PDF]

				B. A. Gilchrest, M. S. Eller, A. C. Geller, and M. Yaar The Pathogenesis of Melanoma Induced by Ultraviolet Radiation N. Engl. J. Med., April 29, 1999; 340(17): 1341 - 1348. [Full Text] [PDF]